9 completed. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 9 |
| Phase 1 | 2 | Completed 2 |
Follow RZL-012: new trials by email Literature Review of RZL-012 trials Research Report on RZL-012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Study That Will Test a Second Treatment Session of RZL-012. RZL-012 - Submental Fat | Phase 2 | Completed | Raziel Therapeutics Ltd. | 15 | 2023-05-29 | 2023-11-18 |
| Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events RZL-012, RZL-012+Lidacaine injection prior treatment, RZL-012+Medrol - Submental Fat | Phase 1 / Phase 2 | Completed | Raziel Therapeutics Ltd. | 48 | 2022-09-25 | 2024-01-30 |
| An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects. RZL-012 - Submental Fat | Phase 1 / Phase 2 | Completed | Raziel Therapeutics Ltd. | 20 | 2022-07-29 | 2023-12-19 |
| Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks RZL-012, Placebo - Flank Mass | Phase 2 | Completed | Raziel Therapeutics Ltd. | 12 | 2022-03-10 | 2023-11-18 |
| Efficacy and Safety of RZL-012 on Submental Fat Reduction RZL-012, Placebo - Submental Fat | Phase 2 | Completed | Raziel Therapeutics Ltd. | 151 | 2021-06-15 | 2023-09-28 |
| RZL-012 for Dercum's Disease Lipomas RZL-012, Vehicle - Dercum's Disease Lipomas | Phase 2 | Completed | Raziel Therapeutics Ltd. | 38 | 2020-07-30 | 2024-02-07 |
| A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers. RZL-012, Placebo - Submental Fat | Phase 2 | Completed | Raziel Therapeutics Ltd. | 28 | 2020-02-25 | 2023-11-18 |
| Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease RZL-012 - Lipedema, Dercum Disease | Phase 2 | Completed | Raziel Therapeutics Ltd. | 12 | 2018-06-28 | 2024-02-08 |
| Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers RZL-012, Placebo - Obesity, Weight Loss | Phase 2 | Completed | Raziel Therapeutics Ltd. | 32 | 2017-07-25 | 2019-08-21 |
Adiposis Dolorosa (1) · Lipedema (1) · Obesity (1) · Overweight (1) · Weight Loss (1)
United States (9)